Contact details

Eibhlin Vardy

T: +44 20 7809 2273 Email Eibhlin | Vcard Office: London

Eibhlin Vardy Senior associate

Contact details

Eibhlin Vardy

Eibhlin Vardy
Senior associate

T: +44 20 7809 2273 Email Eibhlin | Vcard Office: London

Eibhlin’s practice focuses on intellectual property disputes. She has particular expertise in hard fought patent litigation with a cross-jurisdictional element. Eibhlin has also advised in trade secrets and copyright litigation before the English High Court, and acted for clients in disputes concerning trade marks, passing off, and database rights.
  • Profile
  • Services
  • Sectors

Eibhlin is a senior associate in our IP team and has particular experience in the life sciences sector. She has advised an originator pharmaceutical company in the leading second medical use case to reach the English High Court and Court of Appeal, where she advised on both validity and infringement aspects. 

Other career highlights to date include advising BlackBerry in a case concerning a standard essential patent in a High Court dispute with Motorola, and acting for a successful statistical arbitrage hedge fund in a trade secrets dispute in the High Court concerning proprietary algorithmic trading strategies and a proprietary trading platform.

Eibhlin has also completed a 6 month secondment to Novartis’ headquarters in Switzerland.

  • Intellectual property

An originator pharmaceutical company in second medical use case

Eibhlin was the senior associate in the leading second medical use case to reach the English High Court and Court of Appeal.  She advised on validity and infringement issues. 

A successful statistical arbitrage hedge fund in a trade secrets dispute 

Eibhlin acted in a High Court claim issued against a group of former employees concerning the misappropriation of proprietary algorithmic trading strategies and a proprietary trading platform. 

UBS copyright dispute with EIG

She advised UBS in its defence of a copyright infringement claim issued by EIG in the High Court. 

BlackBerry patent infringement/revocation dispute with Motorola

Eibhlin acted for Research In Motion (BlackBerry) in a patent infringement/ revocation action concerning a standard essential patent covering GPRS technology in a High Court dispute with Motorola.

Samsung antitrust dispute with Nokia concerning small sized LCD screens

Eibhlin advised Samsung in its defence of an alleged cartel claim issued by Nokia in relation to small sized LCD screens.

S40 employee inventor compensation claim

Eibhlin acted for a pharmaceutical company in relation to a s40 employee inventor compensation claim.

Genome sequencing company patent infringement dispute

She advised in relation to infringement allegations concerning antenatal genetic screening patents.

In-house experience in life sciences sector

Eibhlin completed a 6 month secondment to Novartis’ headquarters in Switzerland.

More: Intellectual property

  • TMT
  • Life sciences

BlackBerry patent dispute with Motorola

Eibhlin acted for Research In Motion (BlackBerry) in a case concerning a standard essential patent covering GPRS technology in a High Court dispute with Motorola.

Samsung dispute with Nokia concerning small sized LCD screens

Eibhlin advised Samsung in its defence of an alleged cartel claim issued by Nokia in relation to small sized LCD screens.

Patent infringement dispute concerning set top boxes

She provided advice in a patent infringement dispute concerning set top boxes.  

More: TMT

An originator pharmaceutical company in second medical use case

Eibhlin was the senior associate in the leading second medical use case to reach the English High Court and Court of Appeal.  She advised on validity and infringement issues. 

Genome sequencing company patent infringement dispute

She advised in relation to infringement allegations concerning antenatal genetic screening patents.

S40 employee inventor compensation claim

Eibhlin acted for a pharmaceutical company in relation to a s40 employee inventor compensation claim.

In-house experience 

Eibhlin completed a 6 month secondment to Novartis’ headquarters in Switzerland.

More; Life sciences

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.